Acetylcholinesterase and NMDA receptor — Drug Target

All drugs that target Acetylcholinesterase and NMDA receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Cholinesterase inhibitor and NMDA receptor antagonist combination

Marketed (1)

• Rivastigmine, memantine · Novartis · Cholinesterase inhibitor and NMDA receptor antagonist combination · Neurology
  This combination drug enhances acetylcholine levels in the brain while blocking NMDA receptor overactivity to slow cognitive decline in Alzheimer's disease.